|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
-99.00% | - |
| 27/10/21 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/08/21 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 350K 305K 281K 264K 494K 32.97M 498K 3.34M 1.3M 16.25M 1.31M 1.28M 56.31M | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39M 1.21M 1.11M 1.05M 1.96M 131M 1.97M 13.24M 5.14M 64.35M 5.2M 5.09M 223M | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 02/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-15 | Other | 0 | 0% | |||
| 04-15 | Other | 0 | 0% | |||
| 04-15 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 323K 281K 259K 244K 456K 30.41M 459K 3.08M 1.2M 14.99M 1.21M 1.19M 51.94M | 350K 305K 281K 265K 495K 33.02M 499K 3.35M 1.3M 16.27M 1.32M 1.29M 56.4M |
| Net income | -685K -597K -550K -518K -969K -64.58M -975K -6.55M -2.54M -31.83M -2.57M -2.52M -110M | -9.09M -7.92M -7.3M -6.87M -12.85M -857M -12.94M -86.86M -33.73M -422M -34.12M -33.39M -1.46B |
| Net Debt | 1.27M 1.11M 1.02M 962K 1.8M 120M 1.81M 12.17M 4.73M 59.16M 4.78M 4.68M 205M | 1.04M 902K 832K 782K 1.46M 97.61M 1.47M 9.9M 3.84M 48.1M 3.89M 3.8M 167M |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 0.000001 $ | 0.00% | 93,617 |
| 12/06/26 | 0.000001 $ | -99.00% | 156 |
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















